MAPT and Alzheimer disease: Its mRNA levels have also been found to be decreased in peripheral lymphocytes of sporadic AD patients and CD2AP loss of function has been linked to enhanced Aβ production, Tau-induced neurotoxicity, abnormal neurite structure modulation, and reduced blood–brain barrier integrity [43].